Ensuring regulatory compliance by quality by design (QbD) approach to optimize the manufacturing process of API: ferric ammonium citrate as an example

被引:1
|
作者
Jalundhwala, Forum [1 ,2 ]
Londhe, Vaishali [1 ]
Shah, Bharat [2 ]
机构
[1] SVKMs NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, VL Mehta Rd, Mumbai 400056, Maharashtra, India
[2] MIDC, Shreenath Chem, T-54, Boisar 401506, Maharashtra, India
关键词
Quality by design; Central composite design; Ferric ammonium citrate; Regulatory compliance; Process optimization; EMPLOYING QUALITY; DOE; DELIVERY;
D O I
10.1007/s11696-022-02569-3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
It is challenging for a small-scale pharmaceutical manufacturer to comply with evolving regulatory standards. Quality by design (QbD) is a simple solution. The purpose of this study is to demonstrate the use of QbD in optimizing the synthesis of Ferric Ammonium Citrate which will help manufacturers ensure higher regulatory compliance. Three key starting materials (KSM) were reviewed for their synthetic pathways. QbD approach was used to develop the process. The central composite design was used to design experiments of two variables at three levels. Percentage yield, description, and iron content were recorded. Optimized values of variable factors were obtained by contour plots, 3D response surface graphs, and prediction profiler. Repeatability and scale-up were performed with the optimized values. The process was developed using iron powder as KSM and a combination of 50% v/v nitric acid and air bubbling as an oxidizing agent. Risk assessment tools led to selection of variable factors like the quantity of nitric acid and time for air bubbling for optimization. Percentage yield increased with an increase in air bubbling time, whereas the description did not comply with an increase in nitric acid content. All the experiments resulted in iron content within the range. Contour plots and prediction profiler confirmed the optimized values of content of nitric acid as 125 g and air bubbling time of 19 h for a batch size of 400 g. An optimized process leads to fewer variations and better quality assurance. This leads to ensuring higher regulatory compliance.
引用
收藏
页码:1469 / 1477
页数:9
相关论文
共 5 条
  • [1] Ensuring regulatory compliance by quality by design (QbD) approach to optimize the manufacturing process of API: ferric ammonium citrate as an example
    Forum Jalundhwala
    Vaishali Londhe
    Bharat Shah
    Chemical Papers, 2023, 77 : 1469 - 1477
  • [2] A quality by design (QbD) strategy for developing and validating Droxidopa in API and formulation using an RP-HPLC procedure ensuring regulatory compliance
    Maddala, Sandhya Madhuri
    Parimi, Ravi
    Elvina, Pravallika K.
    ANALYTICAL CHEMISTRY LETTERS, 2025,
  • [3] API quality by design example from the torcetrapib manufacturing process
    am Ende D.
    Bronk K.S.
    Mustakis J.
    O'Connor G.
    Santa Maria C.L.
    Nosal R.
    Watson T.J.N.
    Journal of Pharmaceutical Innovation, 2007, 2 (3-4) : 71 - 86
  • [4] Pharmaceutical manufacturing and the quality by design (QBD), process analytical technology (PAT) approach
    Murphy, Trevor
    O'Mahony, Niall
    Panduru, Krishna
    Riordan, Daniel
    Walsh, Joseph
    2016 27TH IRISH SIGNALS AND SYSTEMS CONFERENCE (ISSC), 2016,
  • [5] DEVELOPMENT OF THE MANUFACTURING PROCESS FOR A NOVEL FORMOTEROL/FLUTICASONE COMBINATION HFA PMDI (FLUTIFORM™): APPLICATION OF A QUALITY BY DESIGN (QbD) APPROACH ACCORDING TO ICH Q8 PRINCIPLES
    Gooding, Steve
    Mueller-Walz, Rudi
    Venthoye, Geraldine
    Brindley, Anne
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (04) : A246 - A246